当前位置:首页 - 行情中心 - 傲农生物(603363) - 财务分析 - 现金流量表

傲农生物

(603363)

  

流通市值:41.30亿  总市值:48.74亿
流通股本:7.37亿   总股本:8.70亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金15,203,716,654.4710,125,544,278.714,812,041,400.2821,787,127,631.83
收到其他与经营活动有关的现金337,283,176.87203,841,868.5595,721,602.52382,981,035.99
经营活动现金流入的平衡项目0000
经营活动现金流入小计15,540,999,831.3410,329,386,147.264,907,763,002.822,170,108,667.82
购买商品、接受劳务支付的现金13,250,043,426.478,844,722,295.744,040,264,629.5619,317,265,168.88
支付给职工以及为职工支付的现金1,111,819,444.05760,350,956.59404,815,409.141,476,931,881.77
支付的各项税费88,160,214.9568,143,316.8739,755,583.4699,927,093.11
支付其他与经营活动有关的现金429,682,755.92294,950,462.07170,221,609.96612,347,832.87
经营活动现金流出的平衡项目0000
经营活动现金流出小计14,879,705,841.399,968,167,031.274,655,057,232.1221,506,471,976.63
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额661,293,989.95361,219,115.99252,705,770.68663,636,691.19
二、投资活动产生的现金流量:
收回投资收到的现金4,612,764.23,603,008.98206,2649,124,296
取得投资收益收到的现金163,119.36163,104.9154,173.541,172.38
处置固定资产、无形资产和其他长期资产收回的现金净额7,234,811.24,965,457.62,054,85313,825,145.35
处置子公司及其他营业单位收到的现金净额131,779,067.49121,779,067.4955,555,408.933,126,156.66
收到的其他与投资活动有关的现金30,903,157.926,896,037.7118,706,625.74252,135,312.18
投资活动现金流入的平衡项目0000
投资活动现金流入小计174,692,920.15157,406,676.6876,677,325.21278,212,082.57
购建固定资产、无形资产和其他长期资产支付的现金416,584,715.73326,209,253.12222,280,152.151,498,944,892.4
投资支付的现金--5,000,000107,530,769
取得子公司及其他营业单位支付的现金28,134,920.9324,025,00017,475,00064,893,627.38
支付其他与投资活动有关的现金117,018,619.5116,914,174.6422,565,959.91310,055,860.07
投资活动现金流出的平衡项目0000
投资活动现金流出小计561,738,256.16467,148,427.76267,321,112.061,981,425,148.85
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-387,045,336.01-309,741,751.08-190,643,786.85-1,703,213,066.28
三、筹资活动产生的现金流量:
吸收投资收到的现金38,905,05419,875,05411,010,5541,617,512,596.48
其中:子公司吸收少数股东投资收到的现金38,905,05419,875,05411,010,554185,037,000
取得借款收到的现金4,709,494,177.083,080,685,416.341,293,055,642.545,564,415,006.04
收到其他与筹资活动有关的现金579,222,769.43300,227,150.61206,216,777.641,006,767,199.93
筹资活动现金流入平衡项目0000
筹资活动现金流入小计5,327,622,000.513,400,787,620.951,510,282,974.188,188,694,802.45
偿还债务支付的现金4,694,129,177.72,951,545,437.711,462,570,208.885,220,800,224.87
分配股利、利润或偿付利息支付的现金262,721,342.54182,686,629.4990,140,295.48373,665,464.32
其中:子公司支付给少数股东的股利、利润30,317,183.2928,141,183.2910,703,136.7351,653,854.49
支付其他与筹资活动有关的现金1,069,223,345.63680,663,020.96245,573,827.581,374,053,663.66
筹资活动现金流出平衡项目0000
筹资活动现金流出小计6,026,073,865.873,814,895,088.161,798,284,331.946,968,519,352.85
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-698,451,865.36-414,107,467.21-288,001,357.761,220,175,449.6
四、汇率变动对现金及现金等价物的影响-1,220,031.74-110,364.13201,680.39-2,053,302.2
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-425,423,243.16-362,740,466.43-225,737,693.54178,545,772.31
加:期初现金及现金等价物余额622,508,210.41622,508,210.41622,508,210.41443,962,438.1
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额197,084,967.25259,767,743.98396,770,516.87622,508,210.41
补充资料:
净利润--979,105,672.1--1,226,950,653.42
资产减值准备-71,463,439.52-330,235,546.25
固定资产和投资性房地产折旧-428,899,343.26-844,035,889.09
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-428,899,343.26-844,035,889.09
无形资产摊销-9,726,873.09-16,863,778.58
长期待摊费用摊销-33,446,671-59,472,414.22
处置固定资产、无形资产和其他长期资产的损失--4,491,061.44--2,555,018.49
固定资产报废损失-3,602,696.22-11,965,697.57
公允价值变动损失--1,757,389.16-105,324,370.85
财务费用-250,096,742.34-532,603,044.5
投资损失--41,511,976.65-14,440,449.26
递延所得税--19,486,072.62--103,267,371.3
其中:递延所得税资产减少--13,986,128.98--101,417,882.58
递延所得税负债增加--5,499,943.64--1,849,488.72
存货的减少-457,825,320.83--1,223,488,605.02
经营性应收项目的减少--302,323,621.96--47,361,408.23
经营性应付项目的增加-173,923,272.36-796,910,142.81
其他-26,516,961.4-51,822,549.82
现金的期末余额-259,767,743.98-622,508,210.41
减:现金的期初余额-622,508,210.41-443,962,438.1
公告日期2023-10-282023-08-312023-04-292023-04-29
审计意见(境内)标准无保留意见
TOP↑